Navigation Links
Oldest Heart Patients May Get Most From Warfarin
Date:8/31/2009

In atrial fibrillation study, blood-thinning drug best for those at highest risk of stroke

MONDAY, Aug. 31 (HealthDay News) -- Older patients, or those with a prior history of stroke, are most likely to get a benefit when using warfarin to treat atrial fibrillation, a common heart rhythm disorder, a new study finds.

Kaiser Permanente and Massachusetts General Hospital researchers also say the drug is especially beneficial for patients with multiple risk factors for stroke.

Atrial fibrillation, which occurs when the heart's upper chambers quiver instead of contract, affects more than 2 million Americans. Because the disturbance promotes the formation of blood clots that can travel to the brain and block an artery, atrial fibrillation greatly increases the risk of stroke.

Researchers know that warfarin can prevent such strokes, but the treatment is difficult to control and often leads to hemorrhage. In fact, warfarin is associated with the most emergency admissions for drug-related adverse reactions, according to a Massachusetts General Hospital news release.

Balancing the benefits of warfarin against its severe risks is key to making the best therapeutic decisions for atrial fibrillation patients, study senior author Dr. Alan S. Go, director of the Comprehensive Clinical Research Unit at the Kaiser Permanente Division of Research, said in the news release.

The study appears in the Sept. 1 Annals of Internal Medicine.

Researchers followed almost 13,600 adults with atrial fibrillation treated within Kaiser Permanente of Northern California from 1996 to 2003.

The researchers analyzed rates of the most significant adverse events associated with warfarin therapy -- ischemic stroke, the type produced by arterial blockage; and intracranial hemorrhage, bleeding within and around the brain.

For patients who did and didn't take warfarin, the investigators balanced the reduction in ischemic stroke attributable to treatment against the increase in intracranial bleeding associated with the drug. Since intracranial hemorrhages usually have worse outcomes than ischemic strokes, bleeding events were given greater weight in the comparison.

While warfarin therapy benefited most atrial fibrillation patients, the balance of benefits over risks was greatest in those at highest risk of stroke -- those with multiple risk factors, those with a history of stroke and the oldest patients. Benefits of treatment increased with age, with no clear value seen in patients younger than 65. However, a reduction of more than two strokes per 100 patients was seen in people 85 and older.

More information

The American Heart Association has more on atrial fibrillation here.



SOURCE: Massachusetts General Hospital, news release, Aug. 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Cases of Alzheimers and Dementia Continue to Rise, Even in the Oldest Old
2. New cases of Alzheimers and dementia continue to rise, even in the oldest old
3. Structures from the human immune systems oldest branch shed light on a range of diseases
4. Worlds oldest woman had normal brain
5. Cullen Elected to Chairman of YMCA of Metro Detroit - the Citys Oldest Not-for-Profit
6. DNA Find in Oregon Is Oldest Yet Discovered in Americas
7. Coalition of Caregivers Warns Congress of Danger to Oldest U.S. Seniors if Medicare Slashed
8. This Guys Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations
9. FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
10. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
11. ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oldest Heart Patients May Get Most From Warfarin
(Date:2/22/2017)... ... 2017 , ... The first-ever National Heart Valve Disease Awareness ... join together to increase recognition about the risks of heart valve disease (HVD) ... mark a nationwide movement to raise awareness about a disease that has not ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for Medicare & ... practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate ... Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized and funded ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, a leader in ... the delivery of Platelet Rich Plasma (PRP). PRP systems are used by physicians ... tissue synthesis and provide a faster and more efficient healing process. There are ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... company, launched a new media platform connecting healthcare technology professionals and other key ... followed by a quarterly publication starting on March 1, announced Michael J. Hennessy, ...
(Date:2/22/2017)... ... , ... The SeniorCare Investor will host an important webinar— Seniors Housing M&A: ... 1:00 PM ET. A recording of the webinar will also be made available following ... you want to find out what really happened in the seniors housing and care ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Research and Markets has announced the addition of the ... to their offering. ... Dermatological conditions are one of the most ... US population suffers from at least one active skin condition. ... has remained saturated with established and generic products. However, the ...
(Date:2/22/2017)... Research and Markets has announced the addition of ... Small Molecule Drugs), By Route of Administration (Systemic, Topical), By ... report to their offering. ... The global psoriasis drugs market is anticipated ... report provides a detailed analysis of the current and future ...
(Date:2/22/2017)... , Feb. 22, 2017  Tri-Source Pharma announced today ... A series of newly appointed positions were added to ... CEO, Robert DiCrisci , in the implementation and ... management of the recently consolidated subsidiary companies. ... team will be composed of the following eight members ...
Breaking Medicine Technology: